Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

For patients with large vessel occlusion presenting between 4.5 and 24 hours, intra-arterial tenecteplase after successful ...

For patients with acute ischemic stroke (AIS) whose symptoms began 4.5 to 24 hours earlier, alteplase is associated w ...

A doctor has shared some advice about eating bananas, warning that many of us could be missing out on a whole host of health ...

Discover the alarming link between weight and stroke risk, plus expert-recommended strategies that could protect your brain ...

A drug called buprenorphine may be the best tool doctors have to fight the fentanyl crisis. Why hasn’t it been more widely ...

DONCASTER and Bassetlaw Teaching Hospitals has been named as one of just four NHS sites in England selected to test a new ...

Professor Martin James has been recognised nationally for his pioneering stroke research, including AI-driven treatments and ...

Artificial intelligence is revolutionizing stroke management by improving diagnosis, accelerating treatment, enabling remote ...

Stroke experts from UCSF Health presented new research and clinical findings at the annual the American Stroke Association’s International Stroke Conference (ISC25), the world’s premier meeting ...

Groundbreaking research reveals how common diabetes medications might offer unprecedented protection against heart attacks ...

The findings are disappointing, but questions around intervention timing, patient population, and others remain to be ...